Cabaletta Bio Inc (CABA)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart

Ticker: CABA Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2024-01-19	2024-01-19	PS Planned sale	Binder Gwendolyn See Remarks Officer	700 -3.4% 20.33 USD 14,229	700 -3.4%	20.33	USD 14,229
2024-01-19	2024-01-19	PS Planned sale	Binder Gwendolyn See Remarks Officer	10,300 -33.2% 19.54 USD 201,211	10,300 -33.2%	19.54	USD 201,211
2023-12-19	2023-12-19	PS Planned sale	Binder Gwendolyn See Remarks Officer	3,132 -13.5% 22.22 USD 69,593	3,132 -13.5%	22.22	USD 69,593
2023-12-19	2023-12-19	PS Planned sale	Binder Gwendolyn See Remarks Officer	7,868 -25.4% 21.76 USD 171,196	7,868 -25.4%	21.76	USD 171,196
2023-11-21	2023-11-20	PS Planned sale	Binder Gwendolyn See Remarks Officer	7,458 -27.2% 18.02 USD 134,405	7,458 -27.2%	18.02	USD 134,405
2023-11-21	2023-11-20	PS Planned sale	Binder Gwendolyn See Remarks Officer	3,542 -11.4% 17.39 USD 61,608	3,542 -11.4%	17.39	USD 61,608
2023-10-19	2023-10-19	PS Planned sale	Binder Gwendolyn See Remarks Officer	408 -2.0% 14.28 USD 5,825	408 -2.0%	14.28	USD 5,825
2023-10-19	2023-10-19	PS Planned sale	Binder Gwendolyn See Remarks Officer	10,592 -34.2% 13.32 USD 141,096	10,592 -34.2%	13.32	USD 141,096
2023-09-20	2023-09-19	PS Planned sale	Binder Gwendolyn See Remarks Officer	700 -3.4% 18.50 USD 12,950	700 -3.4%	18.50	USD 12,950
2023-09-20	2023-09-19	PS Planned sale	Binder Gwendolyn See Remarks Officer	10,300 -33.2% 17.50 USD 180,270	10,300 -33.2%	17.50	USD 180,270
2023-08-22	2023-08-21	PS Planned sale	Binder Gwendolyn See Remarks Officer	300 -1.5% 13.82 USD 4,147	300 -1.5%	13.82	USD 4,147
2023-08-22	2023-08-21	PS Planned sale	Binder Gwendolyn See Remarks Officer	10,700 -34.5% 13.41 USD 143,436	10,700 -34.5%	13.41	USD 143,436
2023-07-19	2023-07-19	PS Planned sale	Binder Gwendolyn See Remarks Officer	2,815 -12.3% 14.26 USD 40,143	2,815 -12.3%	14.26	USD 40,143
2023-07-19	2023-07-19	PS Planned sale	Binder Gwendolyn See Remarks Officer	8,185 -26.4% 13.67 USD 111,879	8,185 -26.4%	13.67	USD 111,879
2023-06-21	2023-06-20	PS Planned sale	Binder Gwendolyn See Remarks Officer	11,000 -35.5% 12.99 USD 142,925	11,000 -35.5%	12.99	USD 142,925
2023-05-19	2023-05-19	PS Planned sale	Binder Gwendolyn See Remarks Officer	22,000 -52.4% 11.81 USD 259,833	22,000 -52.4%	11.81	USD 259,833
2022-10-19	2022-10-19	B Purchase	Nichtberger Steven President & CEO Executive Director	8,127 +0.8% 1.25 USD 10,152	8,127 +0.8%	1.25	USD 10,152
2022-10-18	2022-10-18	B Purchase	Simon Mark Non-Executive Director	7,000 +inf% 0.98 USD 6,835	7,000 +inf%	0.98	USD 6,835
2022-10-18	2022-10-18	B Purchase	Simon Mark Non-Executive Director	118,000 +650.4% 0.98 USD 115,286	118,000 +650.4%	0.98	USD 115,286
2022-10-18	2022-10-18	B Purchase	Bollard Catherine Non-Executive Director	1,000 +inf% 0.99 USD 994	1,000 +inf%	0.99	USD 994
2022-10-18	2022-10-18	B Purchase	Binder Gwendolyn See Remarks Officer	20,000 +inf% 0.99 USD 19,894	20,000 +inf%	0.99	USD 19,894
2022-10-18	2022-10-18	B Purchase	Marda Anup Chief Financial Officer Officer	50,000 +inf% 0.99 USD 49,620	50,000 +inf%	0.99	USD 49,620
2022-10-18	2022-10-18	B Purchase	Nichtberger Steven President & CEO Executive Director	141,873 +17.0% 0.99 USD 141,008	141,873 +17.0%	0.99	USD 141,008
2021-11-03	2021-11-01	S Sale	5AM Ventures V, L.P. Large shareholder	36,544 -9.9% 13.00 USD 475,072	36,544 -9.9%	13.00	USD 475,072
2021-11-03	2021-11-01	S Sale	5AM Ventures V, L.P. Large shareholder	258,456 -13.0% 13.00 USD 3,359,928	258,456 -13.0%	13.00	USD 3,359,928
2021-01-12	2021-01-12	S Sale	5AM Ventures V, L.P. Large shareholder	10,530 -2.8% 13.00 USD 136,890	10,530 -2.8%	13.00	USD 136,890
2021-01-12	2021-01-12	S Sale	5AM Ventures V, L.P. Large shareholder	74,470 -2.8% 13.00 USD 968,110	74,470 -2.8%	13.00	USD 968,110
2021-01-12	2021-01-08	S Sale	5AM Ventures V, L.P. Large shareholder	37,411 -9.0% 13.00 USD 486,343	37,411 -9.0%	13.00	USD 486,343
2021-01-12	2021-01-08	S Sale	5AM Ventures V, L.P. Large shareholder	264,589 -9.0% 13.00 USD 3,439,657	264,589 -9.0%	13.00	USD 3,439,657
2020-12-14	2020-12-10	S Sale	5AM Ventures V, L.P. Large shareholder	36,916 -8.1% 14.75 USD 544,511	36,916 -8.1%	14.75	USD 544,511
2020-12-14	2020-12-10	S Sale	5AM Ventures V, L.P. Large shareholder	261,084 -8.1% 14.75 USD 3,850,989	261,084 -8.1%	14.75	USD 3,850,989
2019-10-31	2019-10-29	B Purchase	5AM Ventures V, L.P. Large shareholder	454,545 +inf% 11.00 USD 4,999,995	454,545 +inf%	11.00	USD 4,999,995
2019-10-30	2019-10-29	B Purchase	Flynn James E Large shareholder	700,000 +inf% 11.00 USD 7,700,000	700,000 +inf%	11.00	USD 7,700,000

Cabaletta Bio Inc (CABA)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by